Cargando…
The use of therapeutic drug monitoring for early identification of vedolizumab response in Saudi Arabian patients with inflammatory bowel disease
Vedolizumab is a humanized monoclonal antibody used to treat moderate-to-severe inflammatory bowel disease (IBD). The aim of the study was to assess the effectiveness of the induction of vedolizumab trough level in predicting short-term (week 14) clinical outcomes, and covariates that affect the res...
Autores principales: | Anbarserry, Doaa, Mosli, Mahmoud, Qari, Yousef, Saadah, Omar, Bokhary, Rana, Esmat, Ahmed, Alsieni, Mohammed, Shaker, Ahmed, Elango, Ramu, Alharthi, Sameer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9889342/ https://www.ncbi.nlm.nih.gov/pubmed/36720977 http://dx.doi.org/10.1038/s41598-023-28566-4 |
Ejemplares similares
-
Patterns of Complementary and Alternative Medicine Use in Saudi Arabian Patients With Inflammatory Bowel Disease: A Cross-Sectional Study
por: Altunisi, Albaraa, et al.
Publicado: (2020) -
Magnetic resonance enterography and bowel ultrasonography in Saudi Arabian patients with Crohn's disease: A correlation study
por: Ahmad, Rani, et al.
Publicado: (2021) -
Bowel Damage at Diagnosis Using the Lémann Index Score in Saudi Arabian Patients With Crohn's Disease
por: Halawani, Hajar, et al.
Publicado: (2020) -
Awareness and cognition of illness in Saudi Arabian patients with Crohn's disease
por: Mosli, Mahmoud, et al.
Publicado: (2021) -
Human papillomavirus bowel colonization in inflammatory bowel disease: A comparative case control study
por: Mosli, Mahmoud H., et al.
Publicado: (2022)